《CSCO乳腺癌诊疗指南2024》更新要点解读  

Interpretation on the updated points of Chinese Society of Clinical Oncology(CSCO)2024 breast cancer diagnosis and treatment guidelines

作　　者：胡滢 唐鹏 HU Ying;TANG Peng(Department of Breast and Thyroid Surgery,the First Affiliated Hospital of the Army Military Medical University,Chongqing 400038,China)

机构地区：[1]陆军军医大学第一附属医院乳腺甲状腺外科,重庆400038

出　　处：《现代医药卫生》2024年第11期1809-1813,1822,共6页Journal of Modern Medicine & Health

摘　　要：中国临床肿瘤学会(CSCO)从2016年开始启动编写乳腺癌诊疗指南,并于2017年正式发布,以每年1次的频率进行更新,内容涵盖广,指南均结合我国国情,旨在指导我国相关医务人员、研究人员、医疗及政府机构、患者及家属等更好地做好乳腺癌规范诊疗工作。该文就《CSCO乳腺癌诊疗指南2024》主要更新要点进行解读。The Chinese Society of Clinical Oncology(CSCO)began to compile the guidelines for breast cancer diagnosis and treatment in 2016,and officially released them in 2017.It is updated once a year with a wide range of contents.The guidelines are combined with China′s national conditions,aiming to guide the relevant medical personnel,researchers,medical and government institutions,patients and their families to do a better job in the standardized diagnosis and treatment of breast cancer.This article interpreted the main update points of CSCO 2024 guidelines for breast cancer diagnosis and treatment.

关 键 词：乳腺癌 诊断 治疗 指南 更新要点 

分 类 号：R737.9[医药卫生—肿瘤]